MHRA to trial stem cell robot for cell therapies
Automated stem cell production system undergoes testing: The UK Stem Cell Bank is conducting a 12-month test of a fully automated stem cell production system. The device “has the potential to reduce human error in this process and produce a more consistent final product which will result in safer and more effective treatments,” said Marc Bailey, Chief Ccientific Officer at the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA). The second-ever stem cell-producing robot, being tested by the UK MHRA, could produce safer, cost-effective treatments for diseases like cancer.